Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

Wed, 07th Feb 2024 09:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Redx Pharma PLC, up 35% at 27.00 pence, 12-month range 19.00p-60.00p. The clinical-stage biotechnology company signs an agreement to sell Kirsten rat sarcoma virus inhibitor program to Jazz Pharmaceuticals PLC. Redx says it will receive USD10 million upfront, with a potential for up to USD870 million in development, regulatory and sales milestone payments in addition to royalties on future net sales. Jazz and Redx will collaborate to advance candidates through IND-enabling studies; Jazz will be responsible for all clinical development, regulatory, manufacturing and commercialization activities.

----------

AIM - LOSERS

----------

Verditek PLC, down 19% at 0.12p, 12-month range 0.080p-1.90p. The producer of lightweight solar panels agrees terms to sell its solar business to a new company, which will be established by the holders of Verditek's secured convertible loan notes for GBP528,340 in notes and GBP50,000 in cash. Upon disposal, Verditek will be regarded as an AIM rule 15 cash shell. Verditek will therefore need to, within six months, make an acquisition or acquisitions which constitute a reverse takeover. It said that it is currently in discussions with "a group of individuals", who it is proposed would come in as a new management team with a view to completing a fundraise of about GBP300,000. The aim would be to conduct a reverse takeover within 6 months of completion of the disposal. "There is no guarantee that this proposal will proceed as it still at an exploratory stage and the company will update the market with more information as soon as it is available," Veritek adds.

----------

Helium One Global Ltd, down 16% at 1.81p, 12-month range 0.19p-10.30p. The primary helium explorer raises GBP4.7 million through a placing of 313.3 million new shares priced at 1.5p each. The placing price represents a 30% discount to the closing price of 2.16p on Tuesday. The proceeds will provide the company with "sufficient" working capital to progress its planning for the next stage of the work programme in Tanzania. Chief Executive Lorna Blaisse says: "The results that we have achieved from the Itumbula West-1 well, flowing helium to surface in such significant concentrations, has confirmed a globally unique helium producing province. By moving quickly and finalising this company led placing early on, we have been able to strengthen our working capital position, which will enable us to fully focus on the next phase of the company's growth."

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
9 Sep 2020 12:26

Redx signs new collaboration deal with Jazz Pharmaceuticals

(Sharecast News) - Drug discovery and development company Redx Pharma has signed a new research collaboration agreement with Jazz Pharmaceuticals to discover and develop drug candidates for two cancer targets on the Ras/Raf/MAP kinase (MAPK) pathway.

Read more
5 Aug 2020 15:11

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

Read more
4 Aug 2020 13:58

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

Read more
4 Aug 2020 08:45

Redx Pharma surges on AstraZeneca licensing agreement

(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.

Read more
1 Jul 2020 17:15

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Read more
30 Jun 2020 14:47

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

Read more
18 May 2020 14:39

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

Read more
1 May 2020 14:36

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
9 Apr 2020 18:38

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Read more
2 Apr 2020 18:32

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Read more
30 Mar 2020 17:04

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Read more
13 Mar 2020 10:58

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

Read more
13 Mar 2020 10:31

Redx shares surge on possible cash offer from Yesod

(Sharecast News) - Drug discovery and development company Redx Pharma has received a further private approach from Yesod Bio-Sciences, it announced on Friday, that could lead to a possible cash offer for the entire issued and to be issued share capital of the company, at a price of 15p per share.

Read more
13 Mar 2020 09:26

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.